Skip directly to Accessibility Notice

How to Purchase

PPH
VanEck Vectors Pharmaceutical ETF

Fund Description

VanEck Vectors® Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

 
 

  • Fund Ticker

    PPH
  • Exchange

    NASDAQ
  • Commencement

    12/20/2011
  • ETF Structure

    Physical
  • Administrator

    Van Eck Associates
  • Custodian

    State Street Bank and Trust Company
  • Index Ticker

    MVPPHTR
  • Index Rebalancing

    Quarterly

 
as of 04/07/20

  • 30-Day SEC Yield1

    1.83%
  • Total Net Assets

    $185.8M
  • Number of Holdings

    25
  • Options

    Available
  • Gross Expense Ratio2

    0.42%
  • Net Expense Ratio/TER2

    0.36%
  • Distribution Frequency

    Quarterly
  • Next Distribution Date

    06/30/2020

Key Points

  • Highly Liquid Companies 
    Index seeks to track the most liquid companies in the industry based on market capitalization and trading volume

  • Industry Leaders
    Index methodology favors the largest companies in the industry

  • Global Scope 
    Portfolio may include both domestic and U.S. listed foreign companies, allowing for enhanced industry representation

Trading Information

  • Fund Ticker

    PPH
  • Index Total Return Ticker

    MVPPHTR
  • NAV

    PPHNV
  • Intraday NAV (IIV)4

    PPHIV
  • Shares Outstanding

    3,388,138
  • Estimated Cash

    PPHEU
  • Total Cash

    PPHTC
  • CUSIP

    92189F692
  • ISIN

    US92189F6925
Source: Bloomberg

Fees and Expenses2

  • Management Fee

    0.35%
  • Other Expenses

    0.07%
  • Gross Expense Ratio

    0.42%
  • Fee Waivers and
    Expense Reimbursement

    -0.06%
  • Net Expense Ratio/TER2

    0.36%
2Expenses for PPH are capped contractually at 0.35% until February 1, 2021. Cap excludes acquired fund fees and expenses, interest expense, trading expenses, taxes and extraordinary expenses.

Prices as of 04/07/20

NAV/
Market Price
Volume
30-Day Avg./
Last Trading Day
Daily Change
NAV/
Last Price
YTD Change
NAV/
Last Price
Premium/
Discount
Prem/Discount
Distribution Charts
NAV &
Prem/Discount
History
30-Day
Median
Bid Ask
Spread
NAV
Chart
PPH $54.83
$54.87
129,566
28,116
-$0.36 / -0.05%
$-0.34 / +0.00%
-13.88%
-13.71%
$0.04
0.07%
0.13%

Premium/Discount History as of 04/07/20

Calendar Year 2019 2Q 2019 3Q 2019 4Q 2019 1Q 2020 Premium/Discount Charts NAV & Prem/Discount History
Days closed at a premium 88 23 23 26 22
PPH Days closed at NAV 22 6 2 5 5
Days closed at a discount 142 34 39 33 35

Performance History: Average Annual Total Returns* (%)

1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) -7.81 -4.67 -7.76 -0.70 4.01 -1.19 -- 8.50
PPH (Share Price) -7.86 -4.72 -7.74 -0.83 4.00 -1.20 -- 8.62
MVPPHTR (Index) -7.86 -4.78 -8.08 -0.95 3.94 -1.21 -- 8.44
Performance Differential (NAV - Index) 0.05 0.11 0.32 0.25 0.07 0.02 -- 0.06
1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 3.35 13.42 19.14 19.14 9.06 1.99 -- 9.78
PPH (Share Price) 3.28 13.21 19.53 19.53 9.00 1.97 -- 9.90
MVPPHTR (Index) 3.59 13.67 18.77 18.77 9.00 1.96 -- 9.76
Performance Differential (NAV - Index) -0.24 -0.25 0.37 0.37 0.06 0.03 -- 0.02

Top 10 Holdings (%) as of 02/29/20 Daily Holdings

Total Holdings: 25
Swipe
to view
full data
Holding Name
Ticker
Shares Market Value
(US$)
% of Net
Assets
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA US
689,931
7,954,904 5.52
NOVO NORDISK A/S
NVO US
135,046
7,850,224 5.45
ABBVIE INC
ABBV US
88,566
7,590,992 5.27
ZOETIS INC
ZTS US
55,931
7,451,687 5.17
JOHNSON & JOHNSON
JNJ US
54,469
7,324,991 5.08
BRISTOL-MYERS SQUIBB CO
BMY US
123,037
7,266,565 5.04
SANOFI
SNY US
156,677
7,246,311 5.03
ELI LILLY & CO
LLY US
57,217
7,216,780 5.01
ASTRAZENECA PLC
AZN US
159,348
6,979,442 4.84
NOVARTIS AG
NVS US
82,535
6,929,639 4.81
Top 10 Total (%) 51.22
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Country Weightings (%) as of 02/29/20

  • Country

    % of Net Assets
  • United States

    61.62
  • United Kingdom

    10.73
  • Israel

    5.52
  • Denmark

    5.45
  • France

    5.03
  • Switzerland

    4.81
  • Japan

    4.14
  • Ireland

    2.45
  • Other/Cash

    0.25

Sector Weightings (%) as of 02/29/20

  • Sector

    % of Net Assets
  • Health Care

    99.7
  • Other/Cash

    0.3